Australia - English - Department of Health (Therapeutic Goods Administration)

health spring australia - zinc oxide, quantity: 11 mg (equivalent: zinc, qty 7.18 mg); ferrous fumarate, quantity: 35 mg (equivalent: iron, qty 11.5 mg); nicotinamide, quantity: 17.6 mg; calcium pantothenate, quantity: 14.3 mg; colecalciferol, quantity: 0.011 mg; d-alpha-tocopheryl acid succinate, quantity: 6.6 mg; ascorbic acid, quantity: 75 mg; thiamine hydrochloride, quantity: 6.6 mg; pyridoxine hydrochloride, quantity: 5.5 mg (equivalent: pyridoxine, qty 4.5 mg); biotin, quantity: 110 microgram; cyanocobalamin, quantity: 10 micr - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; povidone; crospovidone; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate; hypromellose; macrogol 400; iron oxide red; iron oxide yellow; titanium dioxide; vanillin; maltodextrin; calcium phosphate; sodium ascorbate; ascorbyl palmitate; mixed (low-alpha type) tocopherols concentrate; acacia; starch sodium octenyl succinate; maize starch; dl-alpha-tocopherol; silicon dioxide; hydrolysed gelatin; hydrogenated soya oil; sucrose - antioxidant/reduce free radicals formed in the body ; maintain/support energy levels ; maintain/support energy production ; helps enhance/promote/increase vitality ; maintain/support vitality ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support (state vitamin/mineral/nutrient) levels in the body

Australia - English - Department of Health (Therapeutic Goods Administration)

health spring australia - zinc oxide, quantity: 12 mg (equivalent: zinc, qty 7.8 mg); ferrous fumarate, quantity: 36.5 mg (equivalent: iron, qty 12 mg); nicotinamide, quantity: 19.2 mg; calcium pantothenate, quantity: 15.6 mg; colecalciferol, quantity: 0.012 mg; d-alpha-tocopheryl acid succinate, quantity: 7.2 mg; ascorbic acid, quantity: 75 mg; thiamine hydrochloride, quantity: 7.2 mg; pyridoxine hydrochloride, quantity: 27 mg (equivalent: pyridoxine, qty 22.2 mg); biotin, quantity: 120 microgram; cyanocobalamin, quantity: 10 micro - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; povidone; crospovidone; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; hypromellose; macrogol 400; iron oxide red; iron oxide yellow; titanium dioxide; vanillin; maltodextrin; calcium phosphate; sodium ascorbate; ascorbyl palmitate; mixed (low-alpha type) tocopherols concentrate; starch sodium octenyl succinate; acacia; sodium starch glycollate; maize starch; dl-alpha-tocopherol; silicon dioxide; hydrolysed gelatin; hydrogenated soya oil; sucrose - antioxidant/reduce free radicals formed in the body ; maintain/support energy levels ; maintain/support energy production ; helps enhance/promote/increase vitality ; maintain/support vitality ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support healthy pregnancy ; help to prevent neural tube defects such as spina bifida and/or anencephaly ; helps prepare the body for pregnancy

Australia - English - Department of Health (Therapeutic Goods Administration)

health spring australia - zinc oxide, quantity: 12 mg (equivalent: zinc, qty 7.8 mg); ferrous fumarate, quantity: 36.5 mg (equivalent: iron, qty 12 mg); nicotinamide, quantity: 19.2 mg; calcium pantothenate, quantity: 15.6 mg; colecalciferol, quantity: 0.012 mg; d-alpha-tocopheryl acid succinate, quantity: 7.2 mg; ascorbic acid, quantity: 75 mg; thiamine hydrochloride, quantity: 7.2 mg; pyridoxine hydrochloride, quantity: 6 mg (equivalent: pyridoxine, qty 4.9 mg); biotin, quantity: 120 microgram; cyanocobalamin, quantity: 10 microgr - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; povidone; crospovidone; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate; hypromellose; macrogol 400; iron oxide red; iron oxide yellow; titanium dioxide; vanillin; maltodextrin; calcium phosphate; sodium ascorbate; ascorbyl palmitate; mixed (low-alpha type) tocopherols concentrate; acacia; starch sodium octenyl succinate; maize starch; dl-alpha-tocopherol; silicon dioxide; hydrolysed gelatin; hydrogenated soya oil; sucrose - antioxidant/reduce free radicals formed in the body ; maintain/support energy levels ; maintain/support energy production ; helps enhance/promote/increase vitality ; maintain/support vitality ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support healthy pregnancy ; help to prevent neural tube defects such as spina bifida and/or anencephaly

United States - English - NLM (National Library of Medicine)

flon laboratories llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

United States - English - NLM (National Library of Medicine)

raw materials international overseas llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi,kenya - ascorbic acid - chewable tablet - ascorbic acid 100mg per tablet. - plain ascorbic acid (vitamin c)

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi, kenya - ascorbic acid - chewable tablet - ascorbic acid 250mg per tablet - plain ascorbic acid (vitamin c)

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi, kenya - ascorbic acid - chewable tablet - ascorbic acid 500mg per tablet - plain ascorbic acid (vitamin c)

United Kingdom - English - myHealthbox

crescent pharma ltd - ascorbic acid - tablets - 50mg - ascorbic acid (vit c), plain - for the treatment of scurvy. prophylactically in cases where deficiency might be expected to occur.

United Kingdom - English - myHealthbox

crescent pharma limited - ascorbic acid - tablets - 100mg - ascorbic acid (vit c), plain - for the treatment of scurvy. prophylactically in cases where deficiency might be expected to occur